About AminoChain
AminoChain is a company based in New York (United States) founded in 2022 by Caspar Barnes.. AminoChain has raised $7.07 million across 1 funding round from investors including Andreessen Horowitz. AminoChain offers products and services including AminoChain Platform and Specimen Center. AminoChain operates in a competitive market with competitors including GenVault Corporation, iSpecimen, Cryoniss, PrecisionMed and ViaCell, among others.
- Headquarter New York, United States
- Founders Caspar Barnes
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.07 M (USD)
in 1 rounds
-
Latest Funding Round
$7.07 M (USD), Series A
Aug 16, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AminoChain
AminoChain offers a comprehensive portfolio of products and services, including AminoChain Platform and Specimen Center. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology connecting stakeholders for biospecimen donation and tracking.
Platform for discovering and acquiring biospecimens for research needs.
Funding Insights of AminoChain
AminoChain has successfully raised a total of $7.07M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.07 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $7.1M
-
First Round
First Round
(16 Aug 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series A - AminoChain | Valuation | a16z |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AminoChain
AminoChain has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Andreessen Horowitz. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AminoChain
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AminoChain
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aminochain Comparisons
Competitors of AminoChain
AminoChain operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, Cryoniss, PrecisionMed and ViaCell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| domain | founded_year | HQ Location |
Provider of a biorepository of human clinical specimens
|
|
| domain | founded_year | HQ Location |
Provider of biobanking services for life sciences industries
|
|
| domain | founded_year | HQ Location |
Human biological materials for research are supplied via a biorepository.
|
|
| domain | founded_year | HQ Location |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about AminoChain
When was AminoChain founded?
AminoChain was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Where is AminoChain located?
AminoChain is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of AminoChain?
Caspar Barnes is the current CEO of AminoChain. They have also founded this company.
Is AminoChain a funded company?
AminoChain is a funded company, having raised a total of $7.07M across 1 funding round to date. The company's 1st funding round was a Series A of $7.07M, raised on Aug 16, 2024.
What does AminoChain do?
AminoChain was founded in 2022 in New York, United States, within the blockchain and biotechnology sectors. A decentralized platform is operated to tokenize stem cell donations and provide incentives for donors. Connections are facilitated between biobanks, clinical sites, and bio-pharma companies via a bio-sample marketplace. Emphasis is given to secure tokenization processes and donor participation mechanisms.
Who are the top competitors of AminoChain?
AminoChain's top competitors include Cryoport, iSpecimen and Clean Cells.
What products or services does AminoChain offer?
AminoChain offers AminoChain Platform and Specimen Center.
Who are AminoChain's investors?
AminoChain has 1 investor. Key investors include Andreessen Horowitz.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.